AQR Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-12,292
| Closed | -$1.99M | – | 2355 |
|
|
2021
Q2 | $1.99M | Sell |
12,292
-4,933
| -29% | -$797K | ﹤0.01% | 1221 |
|
|
2021
Q1 | $2.95M | Sell |
17,225
-3,270
| -16% | -$560K | ﹤0.01% | 998 |
|
|
2020
Q4 | $4.5M | Buy |
20,495
+7,745
| +61% | +$1.7M | 0.01% | 811 |
|
|
2020
Q3 | $2.12M | Sell |
12,750
-3,463
| -21% | -$575K | ﹤0.01% | 1078 |
|
|
2020
Q2 | $1.85M | Buy |
16,213
+993
| +7% | +$113K | ﹤0.01% | 1187 |
|
|
2020
Q1 | $1.17M | Buy |
15,220
+1,556
| +11% | +$120K | ﹤0.01% | 1266 |
|
|
2019
Q4 | $1.76M | Buy |
13,664
+1,725
| +14% | +$222K | ﹤0.01% | 1319 |
|
|
2019
Q3 | $930K | Sell |
11,939
-673
| -5% | -$52.4K | ﹤0.01% | 1538 |
|
|
2019
Q2 | $1.3M | Sell |
12,612
-3,263
| -21% | -$336K | ﹤0.01% | 1403 |
|
|
2019
Q1 | $1.16M | Sell |
15,875
-58,336
| -79% | -$4.28M | ﹤0.01% | 1504 |
|
|
2018
Q4 | $3.15M | Sell |
74,211
-13,209
| -15% | -$560K | ﹤0.01% | 1091 |
|
|
2018
Q3 | $4.12M | Buy |
87,420
+34,501
| +65% | +$1.62M | ﹤0.01% | 1082 |
|
|
2018
Q2 | $2.61M | Buy |
+52,919
| New | +$2.61M | ﹤0.01% | 1305 |
|
|
2017
Q3 | – | Sell |
-26,464
| Closed | -$97K | – | 2300 |
|
|
2017
Q2 | $97K | Hold |
26,464
| – | – | ﹤0.01% | 2177 |
|
|
2017
Q1 | $138K | Sell |
26,464
-30,873
| -54% | -$161K | ﹤0.01% | 2149 |
|
|
2016
Q4 | $272K | Sell |
57,337
-13,195
| -19% | -$62.6K | ﹤0.01% | 2081 |
|
|
2016
Q3 | $466K | Buy |
+70,532
| New | +$466K | ﹤0.01% | 1964 |
|
|
2016
Q2 | – | Sell |
-11,525
| Closed | -$247K | – | 2276 |
|
|
2016
Q1 | $247K | Sell |
11,525
-1,367
| -11% | -$29.3K | ﹤0.01% | 2061 |
|
|
2015
Q4 | $408K | Sell |
12,892
-389
| -3% | -$12.3K | ﹤0.01% | 1944 |
|
|
2015
Q3 | $457K | Buy |
13,281
+830
| +7% | +$28.6K | ﹤0.01% | 1756 |
|
|
2015
Q2 | $392K | Buy |
+12,451
| New | +$392K | ﹤0.01% | 1880 |
|